Single dose planning for radioiodine-131 therapy of Graves' disease

Annals of Nuclear Medicine

Volumn 18, Issue 2, 2004, Pages 151-155

  Kita, Tamotsu ^a,b   Yokoyama, Kunihiko ^a   Kinuya, Seigo ^a   Taki, Junichi ^a   Michigishi, Takatoshi ^a   Tonami, Norihisa ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Dose per thyroid weight; Graves' disease; I 131 therapy

Indexed keywords

IODINE 131;

ADULT; AGED; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; EUTHYROIDISM; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IODINE 131 UPTAKE TEST; PRIORITY JOURNAL; RADIATION ABSORPTION; THYROID FUNCTION; THYROID WEIGHT; TREATMENT PLANNING;

EID: 3042718523     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02985106     Document Type: Article

References (20)

1. Glinoer D, Hesch D, Lagasse R, Laurberg P. The management of hyperthyroidism due to Graves' disease in Europe in 1986: results of an international survey. Acta Endocrinol 1987; 185 (Suppl): 9-37.
2. Nagayama Y, Izumi M, Nagataki S. The management of hyperthyroidism due to Graves' disease in Japan in 1988. Endocrinol Jpn 1989; 36: 299-314.
3. Solomon B, Glinoer D, Lagasse R, Wartofsky L. Current trends in the management of Graves' disease. J Clin Endocrinol Metab 1990; 70: 1518-1524.
4. Catargi BC, Leprat F, Guyot M, Valli N, Ducassou D, Tabarin A. Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and of other possible factors affecting outcome. Eur J Endocrinol 1999; 141: 117-121.
5. Nordyke RA, Gilbert FI. Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease. J Nucl Med 1991; 32: 411-416.
6. Bruin TWAD, Croon CDL, Klerk JMH, Isselt JWV. Standardized radioiodine therapy in Graves' disease: the persistent effect of thyroid weight and radioiodine uptake on outcome. J Intern Med 1994; 236: 507-513.
7. Howarth D, Epstein M, Lan L, Tan P, Booker J. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study. Eur J Nucl Med 2001; 28: 1489-1495.
8. Allahabadia A, Daykin J, Sheppard MC, Gough SCL, Franklin JA. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome. J Clin Endocrinol Metab 2001; 86: 3611-3617.
9. Shapiro B. Optimization of radioiodine therapy of thyrotoxicosis: what have we learned after 50 years? J Nucl Med 1993; 34: 1638-1641.
10. Eriksson E, Eriksson K, Wahlberg P. Treratment of hyperthyroidism with standard doses of radioiodine aiming at ablation. Acta Med Scand 1985; 217: 55-60.
11. Ratcliffe GE, Fogelman I, Maisey MN. The evaluation of radioiodine therapy for thyroid patients using a fixed-dose regime. Br J Radiol 1986; 50: 1105-1107.
12. Willemsen UF, Knesewitsch P, Kreisig T, Pickardt CR, Kirsch CM. Functional results of radioiodine therapy with a 300-Gy absorbed dose in Graves' disease. Eur J Nucl Med 1993; 20: 1051-1055.
13. Gomez N, Gomez JM, Orti A, Gavalda L, Villabona C, Leyes P, et al. Transient hypothyroidism after iodine-131 therapy for Graves' disease. J Nucl Med 1995; 36: 1539-1542.
14. Aizawa Y, Yoshida K, Kaise N, Fukazawa H, Kiso Y, Sayama N, et al. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis. Clin Endocrinol 1997; 46: 1-15.
15. Khanna CM, Sankar R, Magdum M, Gera A. Early development of transient hypothyroidism after I-131 therapy for thyrotoxicosis. J Assoc Physicians India 1998; 46: 268-272.
16. Malone JF, Cullen MJ. Two mechanisms for hypothyroidism after 1311 therapy. Lancet 1976; 2: 73-75.
17. Goolden AWG, Stewart JSW. Long-term results from graded low dose radioactive iodine therapy for thyrotoxicosis. Clin Endocrinol 1986; 24: 217-222.
18. Farrar JJ, Toft AD. Iodine-131 treatment of hypothyroidism: current issues. Clinl Endocrinol 1991; 35: 207-212.
19. Nygaard B, Hegedüs L, Gervil M, Hjalgrim H, Hansen BM, Sce-Jensen P, et al. Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease. J Intern Med 1995; 238: 491-497.
20. Marinelli LD, Quimby EH, Hine GJ. Dosage determination with radioactive isotopes. Am J Roentgenol 1948; 59: 260-281.